Evidence map›Paper›PMID 30422121›Full record

ArticleScientific data2018

High content organelle trafficking enables disease state profiling as powerful tool for disease modelling.

Arun Pal, Hannes Glaß, Marcel Naumann, Nicole Kreiter, Julia Japtok, Ronny Sczech, Andreas Hermann

Abstract readDataset
In one paragraph

Article in Scientific data, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Downstream Effects of Mutations inInternational journal of molecular sciences · 2022
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Arun PalDivision of Neurodegenerative Diseases, Department of Neurology, Technische Universität Dresden, Dresden, Germany.
Hannes GlaßDivision of Neurodegenerative Diseases, Department of Neurology, Technische Universität Dresden, Dresden, Germany.
Marcel NaumannDivision of Neurodegenerative Diseases, Department of Neurology, Technische Universität Dresden, Dresden, Germany.
Nicole KreiterDivision of Neurodegenerative Diseases, Department of Neurology, Technische Universität Dresden, Dresden, Germany.
Julia JaptokDivision of Neurodegenerative Diseases, Department of Neurology, Technische Universität Dresden, Dresden, Germany.
Ronny SczechCenter for Molecular and Cellular Bioengineering, Technische Universität Dresden, Dresden, Germany.
Andreas HermannDivision of Neurodegenerative Diseases, Department of Neurology, Technische Universität Dresden, Dresden, Germany.ORCID 0000-0002-7364-7791

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurodegenerative diseases pose a complex field with various neuronal subtypes and distinct differentially affected intra-neuronal compartments. Modelling of neurodegeneration requires faithful in vitro separation of axons and dendrites, their distal and proximal compartments as well as organelle tracking with defined retrograde versus anterograde directionality. We use microfluidic chambers to achieve compartmentalization and established high throughput live organelle imaging at standardized distal and proximal axonal readout sites in iPSC-derived spinal motor neuron cultures from human amyotrophic lateral sclerosis patients to study trafficking phenotypes of potential disease relevance. Our semi-automated pipeline of organelle tracking with FIJI and KNIME yields quantitative, multiparametric high content phenotypic signatures of organelle morphology and their trafficking in axons. We provide here the resultant large datasets to enable systemic signature interrogations for comprehensive and predictive disease modelling, mechanistic dissection and secondary hit validation (e.g. drug screens, genetic screens). Due to the nearly complete coverage of analysed motility events, our quantitative method yields a bias-free statistical power superior over common analyses of a handful of manual kymographs.

Indexed as

Axonal TransportHigh-Throughput Screening AssaysOrganellesAmyotrophic Lateral SclerosisHumansInduced Pluripotent Stem CellsIntravital MicroscopyMicrofluidic Analytical TechniquesMotor NeuronsNeurodegenerative Diseases

Identifiers

PMID30422121
PMCPMC6233479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.